Monday, October 8, 2001
On the trail of anthrax
The focus on the threat of bioterrorism following the Sept.
11 terrorist attacks has renewed interest in vaccines and treatments for anthrax
infection. Researchers at Harvard Medical School, who have previously published
work on Bacillus anthracis, last week published a second way of attacking the
Most strategies against anthrax focus on its toxins. "The rationale is that antibiotics can effectively rid the body of anthrax but there could still be enough bacterial produced toxin components to kill," said John Collier, professor microbiology and molecular genetics.